Hartford Funds Management Co. LLC Q4 2022 vs. Q1 2023: A Comparison of 13F Holdings

Investors who file with the Securities and Exchange Commission (SEC) must submit a quarterly Form 13F to disclose their holdings. These forms provide insights into institutional investment patterns, including the stock, bond, and options positions held by the largest financial players.

Today, we're examining the 13F holdings comparison between Q4 2022 and Q1 2023 for Hartford Funds Management Co. LLC, which manages more than $160 billion in assets across different fund categories.

Let's dive into the data to see what Hartford Funds Management Co. LLC is buying and selling.

Top Buys

1. The biggest buy for Hartford Funds Management Co. LLC is Otis Worldwide Corp, with shares increasing from 5311 to 6589 during the quarter. The change in value from $415,000 to $556,000 represents a significant 33.7% increase.

2. Hartford Funds Management Co. LLC doubled its shares in Ryanair Holdings PLC, from 2965 in Q4 2022 to 3678 in Q1 2023. However, the value of the position only increased by 56.5%, from $221,000 to $346,000.

3. The company also significantly increased its position in Hilton Worldwide Hldgs Inc, with shares rising from 2028 to 2558 over the quarter. The change in value was substantial, from $256,000 to $360,000, marking a 40.6% increase in value.

Top Sells

1. Hartford Funds Management Co. LLC reduced its position in Sysco Corp by more than 43.6%, from 6163 in Q4 2022 to 3440 in Q1 2023. The change in position value from $471,000 to $265,000 marked a significant decline of 43.6%.

2. Similarly, Pfizer Inc. saw a 13.1% reduction in shares held by Hartford Funds Management Co. LLC, from 17235 in Q4 2022 to 18819 in Q1 2023. The change in position value went from $883,000 to $767,000.

3. Lastly, Colgate Palmolive Co saw a reduction of 15% in shares held by Hartford Funds Management Co. LLC, from 5873 in Q4 2022 to 5232 in Q1 2023. The change in position value saw a decline from $462,000 to $393,000.

Conclusion

In conclusion, Hartford Funds Management Co. LLC increased its position in widely held companies such as Otis Worldwide Corp, Ryanair Holdings PLC, and Hilton Worldwide Hldgs Inc., while reducing its position in Sysco Corp, Pfizer Inc., and Colgate Palmolive Co.

It's important to note that while investors use 13F filings to identify potential buying and selling trends, there are limitations to the data. For example, 13F filings are only released quarterly and can be up to 45 days delayed, making the information less timely. Additionally, 13F reports only provide a snapshot of an investor's holdings and do not include short positions or investments outside of U.S. markets.

That said, it's still valuable to analyze 13F filings to gain insights into the investment behaviors of large institutional investors. And overall, the data suggests that Hartford Funds Management Co. LLC remains bullish on the market, with a net increase in holdings despite some notable position reductions.